Enjoy your salt:, page-4

First 4 Last

slippin

5,835 Posts.

06/09/14

11:02

Post #: 13934423

Originally posted by hanrahan ↑

Column 1 Column 2 Column 3

1 September 3, 2014

Enjoy Your Vices Round 37 — The Salt Controversy

Dear Readers,

Three new studies came out this week shedding more light on the salt controversy. As we've noted for many years, the current fad of salt restriction is ill advised. Though it may create one side benefit — one study[1] showed that people who restricted their salt intake to the American Heart Association recommended guideline of 1.5 gm of sodium a day died at twice the rate of those who didn't — not so good for them, but a nifty cost "benefit" to our over-burdened Social Security system!
Unless there is good reason to do so, salt restriction is a bad idea. This is especially so in people with fibromyalgia, adrenal fatigue and/or autonomic dysfunction (POTS, NMH), where salt restriction will cause you to crash and burn. So my recommendation? Get a good quality sea salt, such as Celtic Sea Salt or even the pink sea salt grinders at Costco, and let your taste buds be your guide.
Read more »
(Also see "Topol on Salt: Time to Shake the Sodium Guidelines?")
Love & blessings,
Dr. T

Here's the graph. Note "Sodium Excretion" is a measure of intake.

Expand

http://www.safesalt.com.au/grainofsalt.html

1 Upvote

Top Stories

NAG

ACCC seeks Olam divestments before it can buy Namoi Cotton

AIM

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

ESK

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

TI1

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

GQG

KalGold rolls out detailed aeromagnetic survey across Pinjin project

There are more pages in this discussion • 14 more messages in this thread...

First 4 Last

Enjoy your salt:, page-4

Top Stories

ACCC seeks Olam divestments before it can buy Namoi Cotton

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

KalGold rolls out detailed aeromagnetic survey across Pinjin project